BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/17/2022 3:36:35 AM | Browse: 314 | Download: 765
 |
Received |
|
2022-04-11 20:34 |
|
Peer-Review Started |
|
2022-04-11 20:36 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-06-27 09:59 |
|
Revised |
|
2022-07-14 02:27 |
|
Second Decision |
|
2022-09-26 03:46 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2022-10-06 02:35 |
|
Articles in Press |
|
2022-10-06 02:35 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2022-10-11 18:42 |
|
Typeset the Manuscript |
|
2022-11-16 06:20 |
|
Publish the Manuscript Online |
|
2022-11-17 03:36 |
| ISSN |
2222-0682 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Surgery |
| Manuscript Type |
Systematic Reviews |
| Article Title |
Impact of gender-affirming hormone therapy on the development of COVID-19 infections and associated complications: A systematic review
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Jennifer J Ferraro, Allie Reynolds, Sylvia Edoigiawerie, Michelle Y Seu, Sydney R Horen, Amir Aminzada and Alireza Hamidian Jahromi |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Alireza Hamidian Jahromi, MD, Doctor, Doctor, Division of Plastic and Reconstructive Surgery, Temple University Health System, 3401 N Broad St., Philadelphia, PA 19140, United States. alirezahamidian@yahoo.com |
| Key Words |
COVID-19; Transgender; Gender-affirming hormone therapy; Gender affirmation; Testosterone; Estrogen |
| Core Tip |
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can produce a wide range of clinical manifestations from asymptomatic to life-threatening. Differences in individual responses to systemic inflammation and coagulopathy appear to be modulated by several factors, including sex steroid hormones. Androgens may facilitate initial COVID-19 infection, however, once this occurs, testosterone may have a protective effect. The role of estrogen and progesterone has also been proposed as potential protective factors in COVID-19 infection. Few studies have investigated the role of gender-affirming hormone therapy in COVID-19 infections. Additional research is necessary to enhance our understanding of this relationship and provide better care for transgender patients. |
| Publish Date |
2022-11-17 03:36 |
| Citation |
Ferraro JJ, Reynolds A, Edoigiawerie S, Seu MY, Horen SR, Aminzada A, Hamidian Jahromi A. Impact of gender-affirming hormone therapy on the development of COVID-19 infections and associated complications: A systematic review. World J Methodol 2022; 12(6): 465-475 |
| URL |
https://www.wjgnet.com/2222-0682/full/v12/i6/465.htm |
| DOI |
https://dx.doi.org/10.5662/wjm.v12.i6.465 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
